Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DY1H2Z
|
|||
| Drug Name |
NCO-48
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 1 | [1] | |
| Company |
Nucorion Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus Polymerase (HBV P) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04629976) Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B. U.S. National Institutes of Health. | |||
| REF 2 | Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.